Santa Cruz Biotechnology features a diverse variety of Transglutaminases monoclonal antibodies for investigating transglutaminases in various biological processes. Transglutaminases monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA) applications.Transglutaminases are a family of enzymes that catalyze the cross-linking of proteins through the formation of covalent bonds, playing a crucial role in cellular processes such as apoptosis, cell adhesion, and tissue repair. The dysregulation of transglutaminases has been implicated in various diseases, including neurodegenerative disorders and cancer, making them significant targets for therapeutic intervention. Understanding transglutaminase function is essential for elucidating their contributions to both normal physiology and disease pathology. Researchers can utilize specific monoclonal antibodies to detect and analyze transglutaminase expression patterns across different tissues and cell types. Advanced imaging techniques combined with transglutaminase monoclonal antibodies enable detailed visualization of protein localization and interactions. Multiple conjugation options, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), provide flexibility in experimental design. Santa Cruz Biotechnology monoclonal antibodies for transglutaminases support researchers worldwide in advancing our understanding of enzyme function and disease mechanisms.